ReviewCancer diagnosis & prognosis

Efficacy of Recombinant Methioninase on Late-stage Patient Cancer in the Histoculture Drug Response Assay (HDRA) as a Potential Functional Biomarker of Sensitivity to Methionine-restriction Therapy in the Clinic.

Yutaro Kubota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.